All In MedTech

Device Trial Radar · NCT03455543

Dual Field PEMF Therapy in Lower Extremity Painful Diabetic Distal Symmetric Peripheral Neuropathy

A Multi-Center, Double-Blind, Sham-Controlled, Randomized Trial of Dual Field PEMF Therapy [Provant® Therapy System] in Lower Extremity Painful Diabetic Distal Symmetric Peripheral Neuropathy (DSPN) (The RELIEF Trial)

Last checked: Nov 20, 2026Latest source record: Jul 15, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 182 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

182

Actual

Start

Mar 26, 2018

Primary completion

Nov 14, 2018

Study completion Jul 18, 2019

Sponsor

Lead sponsor
Regenesis Biomedical, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Mar 6, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Part A of this trial is a multi-center, prospective, double-blinded, sham-controlled, randomized clinical trial. Part A will evaluate PEMF treatment compared to sham treatment in patients with painful diabetic distal symmetric peripheral neuropathy (DSPN) when treatment is administered 30 minutes twice daily through a 120-day period (4 months). Part B is a 8-month open-label active treatment extension period designed to collect longer-term data on pain, medication use, quality of life and safety (Part B).Part B of this trial is a an extension period upon completion of Part A.

Conditions

  • Diabetic Neuropathy Peripheral

Interventions

  • Active Provant Therapy SystemDevice

    Treatment with active Provant Therapy System

  • Inactive (sham) Provant Therapy SystemDevice

    Treatment with inactive Provant Therapy System

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Pain IntensityTime frame: Baseline through 4 months

Locations

18 sites in 1 country. Site status is shown where the registry gives one.

  • Physician's Research Group

    Mesa, Arizona

17 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.